US · Healthcare · Medical Care Facilities
EPS came in at 0.31 against a street estimate of 0.24 — a beat of 29.2%.
Analysts rate Ardent Health Partners, Inc. a buy (7 buy, 5 hold, 1 sell out of 13) with an average price target of $12.67.
| Fund | Stake |
|---|---|
| Chai Trust Co., LLC | 54.77% |
| Ventas Inc | 6.62% |
| BlackRock Inc | 1.54% |
| Ameriprise Financial Inc | 1.50% |
| Goldentree Asset Management LP | 1.12% |
| AQR Capital Management LLC | 1.03% |
| CastleKnight Management LP | 0.76% |
| Vanguard Capital Management, LLC | 0.68% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $1,624,856, compared with $1,576,746 in the third quarter of 2025. • Net income attributable to Ar | 2026-11-05 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 revenue was $1,625 million, up 3.1% year over year. • Net income attributable to Ardent Health was $45 million | 2026-11-04 |
| Board / officer change · Q4 2026 HEADLINE NUMBERS • Ardent Health’s Board reclassified former CEO Martin J. Bonick’s June 2, 2026 departure as a termination for “Cause.” • The compa | 2026-10-23 |
| Company announcement · Q3 2026 ARDENT HEALTH, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Adjusted EBITDA for 2025 revised downward from $545.0 million to $447.3 million — a reduct | 2026-09-04 |
| Quarterly report · Q2 2026 ARDENT HEALTH, INC. — 10-Q SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Revenue (6 months ended June 30, 2026): $3,224,115 thousand ($3.2 b | 2026-08-10 |
| Results announced · Q3 2026 ARDENT HEALTH, INC. — Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Total Revenue Q2 2026: $1,622 million (down 1.4% year-over-year) • Net Income Attri | 2026-08-04 |
| Board / officer change · Q2 2026 ARDENT HEALTH, INC. (ARDT) - FORM 8-K SUMMARY HEADLINE NUMBERS • Reporting Date: June 30, 2026 (Event Date: June 26, 2026) • Company: Ardent Health, | 2026-06-30 |
| Board / officer change · Q2 2026 ARDENT HEALTH, INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • Dave Caspers appointed President and Chief Executive Officer effective June 2, 2026 • Annu | 2026-06-02 |
Readable in the app.
| Announcement | Date |
|---|---|
| Board authorizes $50 million stock repurchase program Ardent Health announced a $50 million stock repurchase program authorized by its Board of Directors on November 17, 2025. The company can buy back its own shares through various methods incl | 2025-11-18 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Ardent Health Partners, Inc. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.